85955-59-5
85955-59-5 structure
- Name: (2S)-1-[(2S)-6-amino-2-[[(1R)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
- Chemical Name: (2S)-1-[(2S)-6-amino-2-[[(1R)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
- CAS Number: 85955-59-5
- Molecular Formula: C21H31N3O5
- Molecular Weight: 405.48800
- Create Date: 2017-10-17 23:29:49
- Modify Date: 2026-08-05 16:07:08
| Name | (2S)-1-[(2S)-6-amino-2-[[(1R)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid |
|---|---|
| Synonyms |
(S)-1-((S)-6-Amino-2-(((R)-1-cboxy-3-phenylpropyl)amino)hexanoyl)pyrrolidine-2-cboxylic acid
(2S)-1-[(2S)-6-amino-2-[[(1R)-1-cboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-cboxylic acid Lisinopril Impurity EQ: What is Lisinopril Impurity E Q: What is the CAS Number of Lisinopril Impurity E Q: What is the storage condition of Lisinopril Impurity E Q: What e the applications of Lisinopril Impurity E N2-((R)-1-carboxy-3-phenylpropyl)-L-lysyl-L-proline Lisinopril Impurity 5(Lisinopril Impurity E) Lisinopril dihydrate impurity E (R)-1-[N2-(1-Cboxy-3-phenylpropyl)-L-lysyl]L-proline Lisinopril Impurity (2S)-1-[(2S)-6-amino-2-[[(2R)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid L-Proline, N2-[(1R)-1-cboxy-3-phenylpropyl]-L-lysyl Lisinopril-Imp-E N2-[(1R)-1-Cboxy-3-phenylpropyl)-L-lysyl]L-proline (R)-Lisinopril Sodium Salt (R) Lisinopril Lisinopril impurity 4/Lisinopril Impurity E/Lisinopril imer Lisinopril (R,S,S)-Isomer |
| Density | 1.252g/cm3 |
|---|---|
| Boiling Point | 666.441ºC at 760 mmHg |
| Molecular Formula | C21H31N3O5 |
| Molecular Weight | 405.48800 |
| Flash Point | 356.851ºC |
| Exact Mass | 405.22600 |
| PSA | 132.96000 |
| LogP | 2.26430 |
| Index of Refraction | 1.578 |
|
~%
85955-59-5 |
| Literature: Wu; Douglas; Ondeyka; Payne; Ikeler; Joshua; Patchett Journal of pharmaceutical sciences, 1985 , vol. 74, # 3 p. 352 - 354 |
|
~0%
85955-59-5 |
| Literature: Boisivon, Frédéric; Debas, Jean; Richet, Gérard Patent: US2011/77412 A1, 2011 ; Location in patent: Page/Page column 2 ; |
|
~%
85955-59-5 |
| Literature: Wu; Douglas; Ondeyka; Payne; Ikeler; Joshua; Patchett Journal of pharmaceutical sciences, 1985 , vol. 74, # 3 p. 352 - 354 |
|
~%
85955-59-5 |
| Literature: Wu; Douglas; Ondeyka; Payne; Ikeler; Joshua; Patchett Journal of pharmaceutical sciences, 1985 , vol. 74, # 3 p. 352 - 354 |
|
~0%
85955-59-5 |
| Literature: Blacklock; Shuman; Butcher; Shearin Jr.; Budavari; Grenda Journal of Organic Chemistry, 1988 , vol. 53, # 4 p. 836 - 844 |
| Precursor 4 | |
|---|---|
| DownStream 0 | |